RecruitingPhase 1NCT03911388
324
studies recruiting now
as of 7 Sept 2026
2,259
studies registered in total
as of 7 Sept 2026
11
countries with a recruiting site
as of 7 Sept 2026
21 Jan 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT04991870
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
RecruitingPhase 1 / Phase 2NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 2NCT06894225
Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
RecruitingPhase 2NCT07356973
Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 324 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Glioblastoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Glioblastoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
5 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Temozolomide (Temodal)
Phase 2Vortioxetine (Brintellix)
Phase 2Fluzoparib
Phase 1/2Ivonescimab
Phase 1Lomustine (Ccnu)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).